Pharmacokinetics of Darunavir/Ritonavir and Rifabutin Coadministered in HIV-Negative Healthy Volunteers

The drug-drug interaction between rifabutin (RFB) and darunavir/ritonavir (DRV/r) was examined in a randomized, three-way crossover study of HIV-negative healthy volunteers who received DRV/r 600/100 mg twice a day (BID) (treatment A), RFB 300 mg once a day (QD) (treatment B), and DRV/r 600/100 mg B...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sekar, Vanitha, Lavreys, Ludo, Van de Casteele, Tom, Berckmans, Cindy, Spinosa-Guzman, Sabrina, Vangeneugden, Tony, De Pauw, Martine, Hoetelmans, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2010
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2944603/
https://ncbi.nlm.nih.gov/pubmed/20660678
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01749-09
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados